Company news

LivaNova PLC news in 2024

LivaNova PLC's news releases, calls and decks from 2024, newest first.

View company

RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression

December 17, 2024

LivaNova to Present Scientific Data at American Epilepsy Society 2024 Annual Meeting

December 4, 2024

LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences

November 13, 2024

LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints

November 10, 2024

LivaNova Reports Third-Quarter 2024 Results

October 29, 2024

LivaNova Appoints Susan Podlogar as a New Director

October 7, 2024

LivaNova to Announce Third-Quarter 2024 Results

September 24, 2024

LivaNova to Present at the Baird Global Healthcare Conference

August 18, 2024

LivaNova Reports Second-Quarter 2024 Results

July 30, 2024

LivaNova to Announce Second-Quarter 2024 Results

June 17, 2024

LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients

June 5, 2024

LivaNova to Present at the Goldman Sachs Healthcare Conference

May 22, 2024

LivaNova Reports First-Quarter 2024 Results

April 30, 2024

LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer

April 29, 2024

LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident

April 24, 2024

LivaNova to Announce First-Quarter 2024 Results

March 20, 2024

LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea

March 19, 2024

LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029

March 4, 2024

LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

March 3, 2024

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

February 20, 2024

LivaNova Announces Vladimir A. Makatsaria as CEO and Board Director

February 4, 2024

LivaNova to Wind Down Advanced Circulatory Support Business Unit

January 7, 2024

LivaNova to Announce Fourth-Quarter and Full-Year 2023 Results

January 3, 2024

Calls in 2024

Decks in 2024